Please login to the form below

Not currently logged in
Email:
Password:

chronic diseases

This page shows the latest chronic diseases news and features for those working in and with pharma, biotech and healthcare.

FDA fast-tracks Jardiance for heart failure review

FDA fast-tracks Jardiance for heart failure review

These studies look at empagliflozin’s impact on cardiovascular death and hospitalisation for heart failure in adults with chronic heart failure with reduced or preserved ejection fraction, respectively. ... Boehringer Ingelheim and Lilly are committed

Latest news

  • Charity launches real-world medical cannabis study Charity launches real-world medical cannabis study

    However, it doesn’t include chronic pain, one of the main uses of cannabis products, and campaigners have said this makes the programme too restrictive. ... the off, including those with chronic pain and other diseases like multiple sclerosis, and

  • GSK’s Nucala gets boost with self-administration approval GSK’s Nucala gets boost with self-administration approval

    Empowering patients to take their medicines at home is an approach that has been successful in other chronic diseases such as diabetes and rheumatoid arthritis.

  • Merck & Co to buy IO specialists Immune Design for $300m Merck & Co to buy IO specialists Immune Design for $300m

    Big pharma, biotech and academia are zeroing in on a range of immune system mechanisms which could prove crucial to fighting diverse diseases. ... other chronic diseases.

  • D-day: time to make digital deliver D-day: time to make digital deliver

    In certain chronic diseases there are large numbers of apps that focus on specific symptoms to help patients manage important aspects of their condition. ... At present, a number of chronic diseases are crowded with a range of treatments in-market and in

  • The Midas Touch The Midas Touch

    So too is the push towards business models that create value beyond the pill, as we are beginning to see in chronic diseases like asthma and diabetes.

More from news
Approximately 2 fully matching, plus 167 partially matching documents found.

Latest Intelligence

  • Rare disease trials Q&A Rare disease trials Q&A

    With 350 million people affected worldwide, rare diseases represent a major unmet medical need. ... Characterised by small, highly heterogeneous patient populations, including children in almost half of the cases, rare diseases are usually genetic and

  • Is anybody listening? Is anybody listening?

    Evidence shows that, in chronic disease areas, if you improve a patient’s knowledge, skills and confidence, those patients recover faster and live longer. ... The research says that online health communities have a major role to play in promoting

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    chronic diseases, as well as advances in treatment and technology.

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    Health systems are stuck in a costly and untenable situation with chronic diseases and so we’re striving for new approaches to keep people well for longer. ... As diseases become more complex, patient care is not just about the pharmaceutical

More from intelligence
Approximately 2 fully matching, plus 44 partially matching documents found.

Latest appointments

  • Kymab appoints its first chief medical officer Kymab appoints its first chief medical officer

    She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.

  • Dr Li Zhou joins TxCell as cell engineering VP Dr Li Zhou joins TxCell as cell engineering VP

    Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ

  • Sanofi’s US pharma head joins Synta as CEO Sanofi’s US pharma head joins Synta as CEO

    She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.

  • Medgenics confirms appointment of Dr Marvin Garovoy

    The company's Biopump uses a patient's own tissue to continuously produce and deliver their protein therapy and, potentially, has applications in a range of chronic diseases, including diabetes, multiple

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics